Acrigen Biosciences
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
202 Stanford Ave, Kensington, California...Phone Number
(415) 361-1422Website
www.acrigen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Acrigen Biosciences
Acrigen Biosciences is focused on revolutionizing medicine through precision gene editing, specifically utilizing CRISPR technology for human therapeutics. The company has developed proprietary gene editing systems, including novel CRISPR-Cas nucleases and engineered anti-CRISPR proteins, to enhance the efficiency and safety of gene editing therapies. Their innovative approach aims to improve the efficacy of treatments for genetic diseases, making a significant impact on patient care. Acrigen is open to collaborations for licensing their advanced CRISPR-Cas Nuclease Library and precision-enhancing proteins.Explore more
Acrigen Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Acrigen Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Acrigen Biosciences
Website visits: Recent activity has been detected on your website
Click to see if Acrigen Biosciences had a recent Job posting/layoffs
Check if Acrigen Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Acrigen Biosciences is spiking on competitors!
Earning: See what the market has to say on Acrigen Biosciences recently announced quarterly report
Product Launch: Get notified when Acrigen Biosciences launches new products
Acrigen Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Acrigen Biosciences has new funding data
Recommended Actions
Reach out to Masked Content who joined Acrigen Biosciences as Masked Content
Find 3 more new buyers
Compare Similar Companies to Acrigen Biosciences
Compare insights from companies similar to Acrigen Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Acrigen Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Acrigen Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Acrigen Biosciences.
Acrigen Biosciences financials insights
Gather financial insights about Acrigen Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$63K
Acrigen Biosciences Tech Stack
A closer look at the technologies used by Acrigen Biosciences
Acrigen Biosciences News & Media
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Acrigen Biosciences
Sign Up For FreeTo access detailed company insights
Acrigen Biosciences is focused on revolutionizing medicine through precision gene editing, specifically utilizing CRISPR technology for human therapeutics. The company has developed proprietary gene editing systems, including novel CRISPR-Cas nucleases and engineered anti-CRISPR proteins, to enhance the efficiency and safety of gene editing therapi... Read More
